Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CLA and weight regain

This article was originally published in The Tan Sheet

Executive Summary

Daily supplementation with conjugated linoleic acid does not prevent weight or fat mass regain, a study published in the March American Journal of Clinical Nutrition finds. Thomas Meinert Larsen, Royal Veterinary & Agricultural University, Frederiksberg, Denmark, et al., placed 122 obese healthy subjects with a Body Mass Index of over 28 on an eight-week diet, then focused on 101 participants who lost >8% of their body weight. Of these participants, 51 took 3.4 g of CLA/day for one year; the remaining 50 took placebo. "After one year, no significant difference in body weight or body fat regain was observed between the treatments," Larsen et al. report. The CLA group regained an average 4.0 kg-5.6 kg of body weight and 2.1 kg-5.0 kg of fat mass while the placebo group reported an average 4.0 kg-5.6 kg gain in body weight and 2.7 kg-4.9 kg gain in fat mass...
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS099171

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel